Pfizer reports it has acquired privately held gene therapy developer Bamboo Therapeutics Inc to boost its presence in the treatment of rare disease. Bamboo was formed in 2014 to advance the work of Dr. Richard Jude Samulski, who used adeno-associated virus vehicle to replace a defective gene … more

Pfizer will advance Western Oncolytics’ novel preclinical oncolytic vaccinia virus, WO-12. “Our goal is to combine WO-12 with our portfolio of promising investigational immunotherapies to explore how these novel combinations could help further enhance the body’s immune response in fighting cancer cells,” said James Merson, Ph.D., CSO, vaccine immunotherapeutics at Pfizer … more